The CM Group Acquires Scientific Commercialization

The CM Group has announced the acquisition of Scientific Commercialization, a Madison, Wisconsin-based business focused on medical affairs consulting and business intelligence software solutions.

“By combining SC’s core competencies with those of The CM Group, we are able to help our clients in a more comprehensive way,” The CM Group’s cofounder, Cherie Myatt said. “The addition of SC’s medical consulting and BI capabilities uniquely positions us to provide our clients with customized solutions along with strategic and tactical capabilities ranging from early clinical and medical engagement through commercialization, based on their stage of development and specific needs.”

Scientific Commercialization provides innovative consulting and analytics to medical affairs and other functions within life sciences and biopharmaceutical companies, including a wide range of services from product strategy, launch and execution to organizational design and process optimization. In addition, they offer a robust suite of business intelligence solutions—including SC-Insight®, social listening and Natural Language Processing—empowering clients to optimize data and bring forward insights that provide real impact to patient and company success.

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!

“I am particularly excited about the business intelligence capabilities that are now integrated into our offering,” Maggie Butler, cofounder of The CM Group said. “We are now able to expand our capabilities and leverage insights to help our clients design programs that improve engagement with health care professionals and patient communities.”

“Our work doesn’t stop with medical affairs,” Daniel Leonard, former CEO of Scientific Commercialization, and current Member of the Board of The CM Group focused on Corporate Development said. “While development of scientific and clinical stories during the early stages are key initial steps in a complex commercialization journey, it goes beyond that. Continued optimization of all relevant communication channels and connecting the right people with the right information is paramount to success. Joining forces with The CM Group’s family of companies is the right step to be able to serve our clients throughout the product lifecycle and I am excited to support this next chapter for both companies.”

  • <<
  • >>

Join the Discussion